Bosnia and Herzegovina vs Czechia: Laboratories providing drug susceptibility testing (DST)
Bosnia and Herzegovina
9.2
in 2014
Czechia
7.6
in 2014
Bosnia and Herzegovina rank
10th
Czechia rank
13th
Laboratories providing drug susceptibility testing (DST) over time
- Bosnia and Herzegovina
- Czechia
How they compare
Bosnia and Herzegovina currently reports 9.2 against 7.6 in Czechia, a difference of 1.6.
That makes Bosnia and Herzegovina's figure about 1.2 times Czechia's.
The two have swapped places 2 times across 9 shared years of data; in 2005 it was Bosnia and Herzegovina ahead.
Bosnia and Herzegovina ranks 10th and Czechia ranks 13th of 157 countries.
Czechia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bosnia and Herzegovina | Czechia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.5 | 6.78 | 0.275 | Czechia |
| 2010s | 5.74 | 8.18 | 2.44 | Czechia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher laboratories providing drug susceptibility testing (dst), Bosnia and Herzegovina or Czechia?
- Bosnia and Herzegovina, at 9.2 against 7.6 in Czechia as of 2014.
- What is the difference in laboratories providing drug susceptibility testing (dst) between Bosnia and Herzegovina and Czechia?
- 1.6, with Bosnia and Herzegovina ahead.
- How many years of comparable data are there for Bosnia and Herzegovina and Czechia?
- 9 years are reported by both, from 2005 to 2014.
- How do Bosnia and Herzegovina and Czechia rank globally for laboratories providing drug susceptibility testing (dst)?
- Bosnia and Herzegovina ranks 10th and Czechia ranks 13th of 157 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Laboratories providing drug susceptibility testing (DST) (per 5 million population). Statizoid refreshes it automatically from the source and publishes the full history for both places.